Annual Working Capital
$11.86 M
-$22.79 M-65.78%
December 31, 2023
Summary
- As of February 7, 2025, CNTX annual working capital is $11.86 million, with the most recent change of -$22.79 million (-65.78%) on December 31, 2023.
- During the last 3 years, CNTX annual working capital has risen by +$21.10 million (+228.18%).
- CNTX annual working capital is now -75.41% below its all-time high of $48.22 million, reached on December 31, 2021.
Performance
CNTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$83.74 M
-$17.36 M-17.17%
September 1, 2024
Summary
- As of February 7, 2025, CNTX quarterly working capital is $83.74 million, with the most recent change of -$17.36 million (-17.17%) on September 1, 2024.
- Over the past year, CNTX quarterly working capital has dropped by -$17.36 million (-17.17%).
- CNTX quarterly working capital is now -17.17% below its all-time high of $101.09 million, reached on June 30, 2024.
Performance
CNTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CNTX Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.8% | -17.2% |
| 3 y3 years | +228.2% | +249.6% |
| 5 y5 years | +149.7% | +249.6% |
CNTX Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.4% | at low | -17.2% | +893.3% |
| 5 y | 5-year | -75.4% | +149.7% | -17.2% | +1005.4% |
| alltime | all time | -75.4% | +149.7% | -17.2% | +1005.4% |
Context Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $83.74 M(-17.2%) |
| Jun 2024 | - | $101.09 M(+1099.2%) |
| Mar 2024 | - | $8.43 M(-28.9%) |
| Dec 2023 | $11.86 M(-65.8%) | $11.86 M(-35.5%) |
| Sep 2023 | - | $18.37 M(-23.3%) |
| Jun 2023 | - | $23.95 M(-16.4%) |
| Mar 2023 | - | $28.65 M(-17.3%) |
| Dec 2022 | $34.65 M | $34.65 M(-8.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $37.93 M(-8.5%) |
| Jun 2022 | - | $41.46 M(-8.4%) |
| Mar 2022 | - | $45.25 M(-6.2%) |
| Dec 2021 | $48.22 M(-621.4%) | $48.22 M(-1314.3%) |
| Sep 2021 | - | -$3.97 M(+49.4%) |
| Jun 2021 | - | -$2.66 M(+59.3%) |
| Mar 2021 | - | -$1.67 M(-82.0%) |
| Dec 2020 | -$9.25 M(-61.3%) | -$9.25 M |
| Dec 2019 | -$23.87 M | - |
FAQ
- What is Context Therapeutics annual working capital?
- What is the all time high annual working capital for Context Therapeutics?
- What is Context Therapeutics annual working capital year-on-year change?
- What is Context Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Context Therapeutics?
- What is Context Therapeutics quarterly working capital year-on-year change?
What is Context Therapeutics annual working capital?
The current annual working capital of CNTX is $11.86 M
What is the all time high annual working capital for Context Therapeutics?
Context Therapeutics all-time high annual working capital is $48.22 M
What is Context Therapeutics annual working capital year-on-year change?
Over the past year, CNTX annual working capital has changed by -$22.79 M (-65.78%)
What is Context Therapeutics quarterly working capital?
The current quarterly working capital of CNTX is $83.74 M
What is the all time high quarterly working capital for Context Therapeutics?
Context Therapeutics all-time high quarterly working capital is $101.09 M
What is Context Therapeutics quarterly working capital year-on-year change?
Over the past year, CNTX quarterly working capital has changed by -$17.36 M (-17.17%)